| Předmět: |
|
| Zdroj: |
Hematology Week; 4/23/2024, p904-904, 1p |
| Abstrakt: |
A recent study conducted at Stanford Hospital and Clinics examined the risk of venous thromboembolism (VTE) in patients undergoing facial feminization surgery while continuing hormone therapy. The study found that the perioperative use of feminizing hormonal therapy does not increase the risk of VTE in these patients. The researchers concluded that it is reasonable to continue these medications through the time of surgery. This information is important for individuals considering facial feminization surgery and can help inform their decision-making process. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
